Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Valitutti

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical & Laboratory Immunology|August 1, 1989
The role of arachidonic acid metabolite PGE2 on T cell proliferative responseS Valitutti, F Castellino, F B Aiello, et al.
Clinical Immunology and Immunopathology|November 1, 1988
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21)L M Larocca, M Piantelli, S Valitutti, et al.
European Journal of Immunology|July 1, 1995
Distinct signaling properties identify functionally different CD4 epitopesC T Baldari, E Milia, M M Di Somma, et al.
International Archives of Allergy and Applied Immunology|January 1, 1990
Interleukin-2 receptor expression in human mast cells and basophilsN Maggiano, F Colotta, F Castellino, et al.
Immunology|May 1, 1989
The expression of functional IL-2 receptor on activated macrophages depends on the stimulus appliedS Valitutti, A Carbone, F Castellino, et al.
Science (New York, N.Y.)|May 9, 2020
Supramolecular attack particles are autonomous killing entities released from cytotoxic T cellsŠ Bálint, S Müller, R Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokinesS Sozzani, F Sallusto, W Luini, et al.
Nature Immunology|March 23, 2001
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector moleculeN Holler, R Zaru, O Micheau, et al.
The Journal of Clinical Investigation|October 28, 1998
HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytesM P Zanni, S von Greyerz, B Schnyder, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical & Laboratory Immunology|August 1, 1989
The role of arachidonic acid metabolite PGE2 on T cell proliferative responseS Valitutti, F Castellino, F B Aiello, et al.
Clinical Immunology and Immunopathology|November 1, 1988
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21)L M Larocca, M Piantelli, S Valitutti, et al.
European Journal of Immunology|July 1, 1995
Distinct signaling properties identify functionally different CD4 epitopesC T Baldari, E Milia, M M Di Somma, et al.
International Archives of Allergy and Applied Immunology|January 1, 1990
Interleukin-2 receptor expression in human mast cells and basophilsN Maggiano, F Colotta, F Castellino, et al.
Immunology|May 1, 1989
The expression of functional IL-2 receptor on activated macrophages depends on the stimulus appliedS Valitutti, A Carbone, F Castellino, et al.
Science (New York, N.Y.)|May 9, 2020
Supramolecular attack particles are autonomous killing entities released from cytotoxic T cellsŠ Bálint, S Müller, R Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokinesS Sozzani, F Sallusto, W Luini, et al.
Nature Immunology|March 23, 2001
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector moleculeN Holler, R Zaru, O Micheau, et al.
The Journal of Clinical Investigation|October 28, 1998
HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytesM P Zanni, S von Greyerz, B Schnyder, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Pageof 4